From October 1, 2023 to December 31, 2023, the company has repurchased 512,262 shares, representing 0.69% for $177.02 million. With this, the company has completed the repurchase of 1,265,661 shares, representing 1.71% for $438.34 million under the buyback announced on February 16, 2023.
West Pharmaceutical Services, Inc.
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
323 USD | -3.10% | +0.13% | -8.28% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.28% | 23.53B | |
-5.31% | 181B | |
-5.38% | 99.95B | |
-6.04% | 66.21B | |
+16.45% | 45.4B | |
-8.08% | 45.36B | |
+8.38% | 43.84B | |
+12.06% | 29.03B | |
+17.98% | 25.64B | |
-10.69% | 22.36B |
- Stock Market
- Equities
- WST Stock
- News West Pharmaceutical Services, Inc.
- Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 16, 2023.